Unlike the liver specific insulin receptor knockout (LIRKO) mouse used in the previous study [23], our Ffar2-/- mice do not exhibit elevated plasma insulin concentrations (see [11]) suggesting possibly that maternal hyperinsulinemia may be driving the early-age metabolic impacts in the offspring. The gene discussed is INS; the disease is hyperinsulinism.